SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce L who wrote (3981)8/7/2000 11:23:59 AM
From: kolo55  Read Replies (3) of 4140
 
I am enjoying it as well.

I have over 200k shares bought at an average price of around 7 1/4. In the black now, and looking forward to Wednesday.

Lehman has reiterated going into the conference call on Wednesday (available on Vcall). This is a very good sign. Lehman has said that SNRS should deliver 110 machines by the end of December in their valuation model. This is an indication that they have confidence that SNRS will do that.

The conference call will cover the orders the company has received, and give some guidance on shipments expected for the current Q ending at the end of September. I expect the company will say that they will be shipping at least 55 machines this Q (half way toward the Lehman forecast). I understand the workers are working OT at Sunrise's facility in Fremont trying to keep up with demand.

From information gathered by some of the bulls on Raging Bull by calling eye doctors around the country, Sunrise is going to blow away the Lehman number by the end of the year. When Visix ramped on their Lasik machines, they were only able to sell and ship 100 machines in the first year. Sunrise is going to do substantially better than that in the first six months.

From an eye doctor who has a machine already delivered, he indicated he won't even begin advertising for several months, since he already has a long waiting list. In fact, with word of mouth carrying the word, he doesn't expect to start advertising until at least six months from now.

Lehman expected $30M in revenues this year, and $80M next year... I think Sunrise will blow both numbers away. And since enough of the revenues will be coming from the $200 per eye royalty, a lot of the money will go to the bottom line. A year from now, it wouldn't surprise me to see this company on target to earn over a dollar per share for 2001.

With 11 million shares short, this is going to be fun.

Paul
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext